Cargando…

Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives

BACKGROUND: In Bangladesh, abortion is illegal except to save a woman’s life, though menstrual regulation (MR) is permitted. MR involves the use of manual uterine aspiration or Misoprostol (with or without Mifepristone) to induce menstruation up to 10–12 weeks from the last menstrual period. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Crouthamel, Bonnie, Pearson, Erin, Tilford, Sarah, Hurst, Samantha, Paul, Dipika, Aqtar, Fahima, Silverman, Jay, Averbach, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993471/
https://www.ncbi.nlm.nih.gov/pubmed/33766050
http://dx.doi.org/10.1186/s12978-021-01123-w
_version_ 1783669568231702528
author Crouthamel, Bonnie
Pearson, Erin
Tilford, Sarah
Hurst, Samantha
Paul, Dipika
Aqtar, Fahima
Silverman, Jay
Averbach, Sarah
author_facet Crouthamel, Bonnie
Pearson, Erin
Tilford, Sarah
Hurst, Samantha
Paul, Dipika
Aqtar, Fahima
Silverman, Jay
Averbach, Sarah
author_sort Crouthamel, Bonnie
collection PubMed
description BACKGROUND: In Bangladesh, abortion is illegal except to save a woman’s life, though menstrual regulation (MR) is permitted. MR involves the use of manual uterine aspiration or Misoprostol (with or without Mifepristone) to induce menstruation up to 10–12 weeks from the last menstrual period. Despite the availability of safe and legal MR services, abortions still occur in informal setttings and are associated with high complication rates, causing women to then seek post abortion care (PAC). The objective of this study is to contextualize MR in Bangladesh and understand systemic barriers to seeking care in formal settings and faciltators to seeking care in informal settings via the perspective of MR providers in an effort to inform interventions to improve MR safety. METHODS: Qualitative individual semi-structured interviews were conducted with 25 trained MR providers (doctors and nurses) from urban tertiary care facilities in six different cities in Bangladesh from April to July, 2018. Interviews explored providers’ knowledge of MR and abortion in Bangladesh, knowledge/experience with informal MR providers, knowledge/experience with patients attempting self-managed abortion, personal attitudes and moral perspectives of MR/abortion in general, and barriers to formal MR. Team based coding and a directed content analysis approach was performed by three researchers. RESULTS: There were three predominant yet overlapping themes: (i) logistics of obtaining MR/PAC/abortion, (ii) provider attitudes, and (iii) overcoming barriers to safe MR. With regards to logistics, lack of consensus among providers revealed challenges with defining MR/abortion gestational age cutoffs. Increasing PAC services may be due to patients purchasing Mifepristone/Misoprostol from pharmacists who do not provide adequate instruction about use, but are logistically easier to access. Patients may be directed to untrained providers by brokers, who intercept patients entering the hospitals/clinics and receive a commission from informal clinics for bringing patients. Provider attitudes and biases about MR can impact who receives care, creating barriers to formal MR for certain patients. Attitudes to MR in informal settings was overwhelmingly negative, which may contribute to delays in care-seeking and complications which endanger patients. Perceived barriers to accessing formal MR include distance, family influence, brokers, and lack of knowledge. CONCLUSIONS: Lack of standardization among providers of MR gestational age cutoffs may affect patient care and MR access, causing some patients to be inappropriately turned away. Providers in urban tertiary care facilities in Bangladesh see primarily the complicated MR/PAC cases, which may impact their negative attitude, and the safety of out-of-clinic/self-managed abortion is unknown. MR safety may be improved by eliminating brokers. A harm reduction approach to improve counseling about MR/abortion care in pharmacies may improve safety and access. Policy makers should consider increasing training of frontline health workers, such as Family Welfare Visitors to provide evidence-based information about Mifepristone/Misoprostol.
format Online
Article
Text
id pubmed-7993471
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79934712021-03-26 Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives Crouthamel, Bonnie Pearson, Erin Tilford, Sarah Hurst, Samantha Paul, Dipika Aqtar, Fahima Silverman, Jay Averbach, Sarah Reprod Health Research BACKGROUND: In Bangladesh, abortion is illegal except to save a woman’s life, though menstrual regulation (MR) is permitted. MR involves the use of manual uterine aspiration or Misoprostol (with or without Mifepristone) to induce menstruation up to 10–12 weeks from the last menstrual period. Despite the availability of safe and legal MR services, abortions still occur in informal setttings and are associated with high complication rates, causing women to then seek post abortion care (PAC). The objective of this study is to contextualize MR in Bangladesh and understand systemic barriers to seeking care in formal settings and faciltators to seeking care in informal settings via the perspective of MR providers in an effort to inform interventions to improve MR safety. METHODS: Qualitative individual semi-structured interviews were conducted with 25 trained MR providers (doctors and nurses) from urban tertiary care facilities in six different cities in Bangladesh from April to July, 2018. Interviews explored providers’ knowledge of MR and abortion in Bangladesh, knowledge/experience with informal MR providers, knowledge/experience with patients attempting self-managed abortion, personal attitudes and moral perspectives of MR/abortion in general, and barriers to formal MR. Team based coding and a directed content analysis approach was performed by three researchers. RESULTS: There were three predominant yet overlapping themes: (i) logistics of obtaining MR/PAC/abortion, (ii) provider attitudes, and (iii) overcoming barriers to safe MR. With regards to logistics, lack of consensus among providers revealed challenges with defining MR/abortion gestational age cutoffs. Increasing PAC services may be due to patients purchasing Mifepristone/Misoprostol from pharmacists who do not provide adequate instruction about use, but are logistically easier to access. Patients may be directed to untrained providers by brokers, who intercept patients entering the hospitals/clinics and receive a commission from informal clinics for bringing patients. Provider attitudes and biases about MR can impact who receives care, creating barriers to formal MR for certain patients. Attitudes to MR in informal settings was overwhelmingly negative, which may contribute to delays in care-seeking and complications which endanger patients. Perceived barriers to accessing formal MR include distance, family influence, brokers, and lack of knowledge. CONCLUSIONS: Lack of standardization among providers of MR gestational age cutoffs may affect patient care and MR access, causing some patients to be inappropriately turned away. Providers in urban tertiary care facilities in Bangladesh see primarily the complicated MR/PAC cases, which may impact their negative attitude, and the safety of out-of-clinic/self-managed abortion is unknown. MR safety may be improved by eliminating brokers. A harm reduction approach to improve counseling about MR/abortion care in pharmacies may improve safety and access. Policy makers should consider increasing training of frontline health workers, such as Family Welfare Visitors to provide evidence-based information about Mifepristone/Misoprostol. BioMed Central 2021-03-25 /pmc/articles/PMC7993471/ /pubmed/33766050 http://dx.doi.org/10.1186/s12978-021-01123-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Crouthamel, Bonnie
Pearson, Erin
Tilford, Sarah
Hurst, Samantha
Paul, Dipika
Aqtar, Fahima
Silverman, Jay
Averbach, Sarah
Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives
title Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives
title_full Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives
title_fullStr Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives
title_full_unstemmed Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives
title_short Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives
title_sort out-of-clinic and self-managed abortion in bangladesh: menstrual regulation provider perspectives
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993471/
https://www.ncbi.nlm.nih.gov/pubmed/33766050
http://dx.doi.org/10.1186/s12978-021-01123-w
work_keys_str_mv AT crouthamelbonnie outofclinicandselfmanagedabortioninbangladeshmenstrualregulationproviderperspectives
AT pearsonerin outofclinicandselfmanagedabortioninbangladeshmenstrualregulationproviderperspectives
AT tilfordsarah outofclinicandselfmanagedabortioninbangladeshmenstrualregulationproviderperspectives
AT hurstsamantha outofclinicandselfmanagedabortioninbangladeshmenstrualregulationproviderperspectives
AT pauldipika outofclinicandselfmanagedabortioninbangladeshmenstrualregulationproviderperspectives
AT aqtarfahima outofclinicandselfmanagedabortioninbangladeshmenstrualregulationproviderperspectives
AT silvermanjay outofclinicandselfmanagedabortioninbangladeshmenstrualregulationproviderperspectives
AT averbachsarah outofclinicandselfmanagedabortioninbangladeshmenstrualregulationproviderperspectives